5-Ethynylarylnaphthalimides as antitumor agents: Synthesis and biological evaluation. 2017

Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
Instituto Universitario de Bio-Orgánica Antonio González (CIBICAN), Departamento de Química Orgánica, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez 2, 38206 La Laguna, Tenerife, Spain.

A set of 5-ethynylarylnaphthalimides was synthesized by Sonogashira cross-coupling reactions and evaluated for antiproliferative and antitopoisomerase II in vitro activities. Furthermore docking studies of these molecules as DNA-intercalators were carried out and the in vivo DNA-damaging activity was also determined with the model organism Saccharomyces cerevisiae. From the obtained results three naphthalimides 6, 13 and 14 showed strong topoisomerase II inhibitory activity. These three molecules also presented good docking scores as DNA-intercalators using a self-complementary oligodeoxynucleotide d(ATGCAT)2 as a model, and compounds 13 and 14 were among the most cytotoxic in the in vivo DNA-damaging activity.

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012441 Saccharomyces cerevisiae A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D053644 Naphthalimides Compounds with three fused rings that appear like a naphthalene fused to piperidone or like a benz(de)isoquinoline-1,3-dione (not to be confused with BENZYLISOQUINOLINES which have a methyl separating the naphthyl from the benzyl rings). Members are CYTOTOXINS. Naphthalimide
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass
D066241 Carbon-13 Magnetic Resonance Spectroscopy Magnetic resonance spectroscopy involving detection of changes in the resonance of carbon-13 nuclei in organic molecules. 13C NMR,Carbon 13 Magnetic Resonance Spectroscopy
D066244 Proton Magnetic Resonance Spectroscopy Spectroscopy technique which measures changes in organic compounds by tracking the spectral energy of absorption of HYDROGEN atoms. 1H NMR,1H-MRS,1H-NMR

Related Publications

Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
January 1998, Bioorganic & medicinal chemistry letters,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
July 2010, Bioorganic & medicinal chemistry letters,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
March 2020, Future medicinal chemistry,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
June 2013, Archives of pharmacal research,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
November 2018, Molecules (Basel, Switzerland),
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
June 2013, European journal of medicinal chemistry,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
April 2013, European journal of medicinal chemistry,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
January 2015, European journal of medicinal chemistry,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
February 2014, Bioorganic & medicinal chemistry letters,
Patricia Quintana-Espinoza, and Pedro Martín-Acosta, and Ángel Amesty, and Patricia Martín-Rodríguez, and Isabel Lorenzo-Castrillejo, and Leandro Fernández-Pérez, and Félix Machín, and Ana Estévez-Braun
March 2014, Chemical biology & drug design,
Copied contents to your clipboard!